Inactivating mutations in the COMPASS histone methyltransferase complex, which occur in 40% of human breast cancers, can cooperate with activating PI3K mutations to also elicit aberrant differentiation programs; in this case, however, these mutations promote the genesis of luminal-like tumors from basal cells (124). Here, PIK3CA is linked to breast carcinoma.